MBNKO
MEDALLION FINANCIAL CORP
$25.89
+0.14%
$25.9M
No data for this timeframe.
Vol
Market Cap$25.9M
Cap SizeNano Cap
SEC Reports6
Recent Activity
Jun 5, 2026
SEC
Medallion Financial Corp. filed a DEFA14A on June 4, 2026, issuing a press release that rebuts activist ZimCal's claims
DEFA14A — Impact 5/10
Jun 4, 2026
SEC
Medallion Financial's subsidiary, Medallion Capital, received SBA notification that submitting two candidates cures a pr
8-K — Impact 6/10
Jun 3, 2026
SEC
Medallion Financial Corp. filed additional definitive proxy soliciting materials (DEFA14A) on June 3, 2026, urging share
DEFA14A — Impact 5/10
Latest Reports
NEUTRAL
DEFA14A
5/10
Medallion Financial Corp. filed a DEFA14A on June 4, 2026, issuing a press release that rebuts activist ZimCal's claims
Jun 5, 2026
BULLISH
8-K
6/10
Medallion Financial's subsidiary, Medallion Capital, received SBA notification that submitting two candidates cures a pr
Jun 4, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 2 mixed, 2 neutral. Avg impact: 5.8/10.
NEUTRAL
DEFA14A
5/10
Medallion Financial Corp. filed a DEFA14A on June 4, 2026, issuing a press release that rebuts activ
Jun 5, 2026
BULLISH
8-K
6/10
Medallion Financial's subsidiary, Medallion Capital, received SBA notification that submitting two c
Jun 4, 2026
NEUTRAL
DEFA14A
5/10
Medallion Financial Corp. filed additional definitive proxy soliciting materials (DEFA14A) on June 3
Jun 3, 2026
MIXED
DEFA14A
6/10
Medallion Financial Corp. filed a DEFA14A responding to Glass Lewis's negative recommendation agains
Jun 2, 2026
MIXED
PREC14A
6/10
Medallion Financial Corp. is facing a contested board election at its 2026 annual meeting, with acti
Apr 17, 2026
BEARISH
8-K
7/10
The SBA has declared an event of default on $73.5 million in debentures issued to Medallion Financia
Apr 3, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.